Bettapharma

Bettapharma mainly providing customers with products such as Ectinib hydrochlorid

Beda Pharmaceuticals is an innovative drug developer in the fields of malignancy, ophthalmology, autoimmune diseases and diabetes, mainly providing customers with products such as Ectinib hydrochloride (Kemena), new antineoplastic drug CM082 and other products, including six national Class I and Class II new drugs, and 14 national Class III and Class IV new drugs in the pipeline.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

-

Founded

Jan 1, 2003

HQ location

Zhejiang, China

Legal name

Betta Pharmaceuticals Co., Ltd.

Employees

501-1000

See more